Tecogen Appoints Dr. John M Albertine to Board of Directors
Tecogen (OTCQX: TGEN) has announced the appointment of Dr. John M. Albertine to its Board of Directors. Dr. Albertine brings extensive experience from his service on various public boards, including Fruit of the Loom and Thermo Electron Corporation. He is currently the CEO of Albertine Enterprises and a Managing Partner at JJ&B. Tecogen's CEO, Benjamin Locke, expressed optimism about Dr. Albertine's contributions to the company’s growth and governance, particularly in the audit committee.
- Dr. Albertine's extensive board experience is expected to provide valuable insights for Tecogen.
- His background in economics can enhance strategic financial decisions.
- No direct experience in the energy sector could pose challenges in industry-specific governance.
- Potential gaps in continuity as new members may need time to acclimate.
WALTHAM, MA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Tecogen Inc. (OTCQX: TGEN), a clean energy company providing ultra-efficient and clean on-site power, heating, and cooling equipment, is pleased to announce the appointment of Dr. John M Albertine to the Board of Directors. Dr. Albertine has served on the Board of numerous public companies including Fruit of the Loom, Thermo Electron Corporation (now Thermo Fisher Corporation), American Precision Industries, Intersections Inc, DynaTech Corporation and Kadant inc. He has also served as the Vice Chairman of the Fruit of the Loom Company and has served on two Presidential Commissions under President Reagan. Presently he is the CEO of Albertine Enterprises Inc. a public policy and advocacy firm based in Washington DC. He is also the Managing Partner at JJ&B an investment banking firm. Dr. Albertine has a Ph.D. in Economics from the University of Virginia and Doctor of Humanities (honorary) from King’s College, PA. He was also the Chair of the Economics Department at the Mary Washington College of the University of Virginia and an Adjunct Professor at the US Marine Corps, Command and Staff College at Quantico.
“We are honored to have Dr. Albertine join our board of directors. His knowledge and wealth of expertise serving on the boards of public companies is invaluable,” said Benjamin Locke, CEO of Tecogen. “We look forward to his contributions as a board member and a member of our audit committee as Tecogen grows.”
About Tecogen
Tecogen Inc. designs, manufactures, installs, and maintains high efficiency and ultra-clean cogeneration products, including combined heat and power systems, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational, and industrial applications. The company’s cost efficient, reliable, and environmentally friendly products for energy production nearly eliminate criteria pollutants and significantly reduce customers’ carbon footprint.
In business for over 35 years, Tecogen has shipped more than 3,150 units, supported by an established network of engineering, sales, and service personnel throughout North America. Aggregate run hours on Tecogen’s InVerde cogeneration systems exceeds 5 million hours. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.
Tecogen, InVerde e+, Ilios, Tecochill, Tecofrost, Tecopack, Tecopower, and Ultera are registered trademarks of Tecogen Inc.
Forward Looking Statements
This press release contains “forward-looking statements” which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "likely" or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.
In addition to the Risk Factors described in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q under “Risk Factors,” factors that could cause our actual results to differ materially from past and projected future results include the impact of the coronavirus pandemic on demand for our products and services, the availability of incentives, rebates and tax benefits relating to our products, changes in the regulatory environment relating to our products, competing technological developments, and the availability of financing to fund our operations and growth.
Tecogen Media & Investor Relations Contact Information:
Benjamin Locke, CEO
P: (781) 466-6402
E: Benjamin.Locke@Tecogen.com
FAQ
Who is the new board member appointed by Tecogen?
What experience does Dr. Albertine bring to Tecogen?
What is the expected impact of Dr. Albertine's appointment on Tecogen?
When was Dr. Albertine appointed to the board of Tecogen?
